Geneos Wealth Management’s EQT Corp EQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $436K | Hold |
8,200
| – | – | 0.01% | 773 |
|
|
2026
Q1 | $522K | Buy |
8,200
+530
| +7% | +$31.1K | 0.01% | 684 |
|
|
2025
Q4 | $411K | Hold |
7,670
| – | – | 0.01% | 721 |
|
|
2025
Q3 | $417K | Sell |
7,670
-636
| -8% | -$33.6K | 0.01% | 701 |
|
|
2025
Q2 | $484K | Buy |
8,306
+3,005
| +57% | +$162K | 0.01% | 717 |
|
|
2025
Q1 | $283K | Buy |
5,301
+1,273
| +32% | +$65K | 0.01% | 790 |
|
|
2024
Q4 | $186K | Buy |
4,028
+85
| +2% | +$3.5K | 0.01% | 869 |
|
|
2024
Q3 | $144K | Buy |
3,943
+743
| +23% | +$25.3K | 0.01% | 861 |
|
|
2024
Q2 | $118K | Buy |
3,200
+1,000
| +45% | +$39.2K | 0.01% | 826 |
|
|
2024
Q1 | $81.6K | Sell |
2,200
-161
| -7% | -$5.77K | ﹤0.01% | 910 |
|
|
2023
Q4 | $91.3K | Buy |
2,361
+54
| +2% | +$2.19K | ﹤0.01% | 866 |
|
|
2023
Q3 | $93.6K | Sell |
2,307
-1,043
| -31% | -$43.2K | ﹤0.01% | 895 |
|
|
2023
Q2 | $138K | Sell |
3,350
-127
| -4% | -$4.49K | 0.01% | 781 |
|
|
2023
Q1 | $111K | Buy |
3,477
+27
| +0.8% | +$866 | 0.01% | 815 |
|
|
2022
Q4 | $117K | Hold |
3,450
| – | – | 0.01% | 786 |
|
|
2022
Q3 | $140K | Buy |
3,450
+1,045
| +43% | +$45.3K | 0.01% | 706 |
|
|
2022
Q2 | $82K | Sell |
2,405
-200
| -8% | -$8.24K | ﹤0.01% | 1086 |
|
|
2022
Q1 | $89K | Buy |
2,605
+351
| +16% | +$8.56K | ﹤0.01% | 1135 |
|
|
2021
Q4 | $49K | Buy |
2,254
+450
| +25% | +$9.41K | ﹤0.01% | 1488 |
|
|
2021
Q3 | $37K | Hold |
1,804
| – | – | ﹤0.01% | 1629 |
|
|
2021
Q2 | $38K | Sell |
1,804
-236
| -12% | -$4.76K | ﹤0.01% | 1610 |
|
|
2021
Q1 | $38K | Hold |
2,040
| – | – | ﹤0.01% | 1770 |
|
|
2020
Q4 | $35K | Buy |
2,040
+236
| +13% | +$3.4K | ﹤0.01% | 1626 |
|
|
2020
Q3 | $25K | Hold |
1,804
| – | – | ﹤0.01% | 1546 |
|
|
2020
Q2 | $19K | Hold |
1,804
| – | – | ﹤0.01% | 1638 |
|
|
2020
Q1 | $12K | Buy |
1,804
+1
| +0.1% | +$7 | ﹤0.01% | 1720 |
|
|
2019
Q4 | $18K | Hold |
1,803
| – | – | ﹤0.01% | 1729 |
|
|
2019
Q3 | $20K | Hold |
1,803
| – | – | ﹤0.01% | 1602 |
|
|
2019
Q2 | $28K | Buy |
1,803
+1
| +0.1% | +$19 | ﹤0.01% | 1464 |
|
|
2019
Q1 | $37K | Hold |
1,802
| – | – | ﹤0.01% | 1286 |
|
|
2018
Q4 | $34K | Sell |
1,802
-1,508
| -46% | -$30.6K | ﹤0.01% | 1272 |
|
|
2018
Q3 | $79K | Sell |
3,310
-551
| -14% | -$15.2K | 0.01% | 974 |
|
|
2018
Q2 | $116K | Sell |
3,861
-100
| -3% | -$2.79K | 0.01% | 734 |
|
|
2018
Q1 | $102K | Buy |
3,961
+2,723
| +220% | +$78.1K | 0.01% | 744 |
|
|
2017
Q4 | $38K | Hold |
1,238
| – | – | ﹤0.01% | 1122 |
|
|
2017
Q3 | $43K | Hold |
1,238
| – | – | ﹤0.01% | 1019 |
|
|
2017
Q2 | $39K | Sell |
1,238
-658
| -35% | -$20.8K | ﹤0.01% | 1022 |
|
|
2017
Q1 | $63K | Buy |
1,896
+537
| +40% | +$17.9K | 0.01% | 809 |
|
|
2016
Q4 | $48K | Hold |
1,359
| – | – | 0.01% | 854 |
|
|
2016
Q3 | $53K | Buy |
1,359
+33
| +2% | +$1.3K | 0.01% | 791 |
|
|
2016
Q2 | $57K | Hold |
1,326
| – | – | 0.01% | 756 |
|
|
2016
Q1 | $48K | Buy |
+1,326
| New | +$42.4K | 0.01% | 811 |
|
Other funds holding EQT
OAG
Geneos Wealth Management's EQT Position: Q2 2026 in Review
Geneos Wealth Management held its EQT Corp (EQT) position steady in Q2 2026 at 8,200 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #773.
Geneos Wealth Management first reported a position in EQT in Q1 2016 and has held it in 42 quarters since. The position peaked at $522K in Q1 2026. 1,110 funds tracked by Wall St. Rank hold EQT as of Q2 2026.
- Geneos Wealth Management held 8,200 shares of EQT Corp worth $436K as of Q2 2026.
- Geneos Wealth Management left its EQT Corp share count unchanged in Q2 2026.
- EQT Corp made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #773 holding.
- Geneos Wealth Management first reported a position in EQT Corp in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's EQT Corp position peaked at $522K in Q1 2026.
- 1,110 funds tracked by Wall St. Rank held EQT Corp as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.